Document Detail

Nipple-sparing mastectomy and immediate tissue expander/implant breast reconstruction.
MedLine Citation:
PMID:  19952633     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: The nipple is an uncommon site for breast cancer development, but the nipple-areola complex is routinely excised in breast cancer treatment. The authors evaluated the risks and benefits of nipple- or areola-sparing mastectomy with breast reconstruction.
METHODS: The authors analyzed data on 115 consecutive nipple- or areola-sparing mastectomies with immediate tissue expander breast reconstruction performed in 66 patients from 1998 to 2008 at a single tertiary-care cancer center. Nipple-sparing mastectomies were performed for prophylaxis (n = 75) or treatment of disease (n = 40).
RESULTS: Mean patient age was 45 years (range, 24 to 61 years) and mean follow-up time was 22 months (range, 2 weeks to 91 months). There were 115 nipple- or areola-sparing mastectomies (48 bilateral and 19 unilateral), including 111 nipple-sparing and four areola-sparing mastectomies. On pathologic review, 20 breasts had ductal carcinoma in situ, 20 breasts had invasive cancer, 11 breasts had lobular carcinoma in situ, one breast had phyllodes tumor, one breast had mucinous carcinoma, and 62 breasts were cancer-free. Incision placement was periareolar and radial (n = 61), inframammary (n = 25), omega type (n = 14), customized to include a previous scar (n = 10), or transareolar (n = 5). Of all 115 nipple- or areola-sparing mastectomies, six nipples were lost because of occult disease (5.2 percent), and four nipples were lost because of wound-healing problems (3.5 percent).
CONCLUSIONS: In the authors' series of nipple- and areola-sparing mastectomies performed for risk reduction or breast cancer, there was a low incidence of occult disease (5.2 percent). Nipple- and areola-sparing mastectomy may be feasible in selected patients and should be the subject of additional investigation.
Constance M Chen; Joseph J Disa; Virgilio Sacchini; Andrea L Pusic; Babak J Mehrara; Carlos A Garcia-Etienne; Peter G Cordeiro
Related Documents :
21224133 - Not all patients pursue prostate biopsy after abnormal prostate specific antigen results.
21980323 - Metastatic signet ring cell carcinoma of the bilateral breasts and ovaries from gastroi...
23179663 - A multi-ethnic breast cancer case-control study in new zealand: evidence of differentia...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Plastic and reconstructive surgery     Volume:  124     ISSN:  1529-4242     ISO Abbreviation:  Plast. Reconstr. Surg.     Publication Date:  2009 Dec 
Date Detail:
Created Date:  2009-12-02     Completed Date:  2010-01-11     Revised Date:  2014-10-13    
Medline Journal Info:
Nlm Unique ID:  1306050     Medline TA:  Plast Reconstr Surg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1772-80     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Breast Implants
Breast Neoplasms / pathology,  surgery
Cohort Studies
Follow-Up Studies
Graft Rejection
Graft Survival
Mammaplasty / methods*
Mastectomy, Subcutaneous / methods*
Middle Aged
Neoplasm Invasiveness / pathology
Neoplasm Recurrence, Local / epidemiology*,  pathology
Neoplasm Staging
Nipples / pathology*
Patient Satisfaction
Patient Selection
Postoperative Care / methods
Retrospective Studies
Risk Assessment
Time Factors
Tissue Expansion Devices*
Treatment Outcome
Young Adult

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Three- and four-dimensional arterial and venous perforasomes of the internal mammary artery perforat...
Next Document:  Preferences in choosing between breast reconstruction options: a survey of female plastic surgeons.